For the broader GLP-1 market, Canadas first generic semaglutide approval shows how the access debate is shifting from shortage-era workarounds to formal generic competition, with each countrys patent rules determining the pace
Red Flags to Avoid Certain warning signs indicate vendors likely to provide substandard products or problematic service
To support your health goals effectively, consider using our GLP-1 app to track your protein intake and more
Brand Names You Might Recognize: Wegovy, Ozempic, and Rybelsus Youll hear a few different names associated with semaglutide, and its helpful to know the distinction: Wegovy: This is the version of semaglutide that is specifically FDA-approved for chronic weight management in adults and adolescents
OASIS 4 (Rybelsus, obesity, December 2025): 71-week Phase 3 trial in adults with obesity using once-daily oral semaglutide 25 mg